Skip to content

Effect of Transcutaneous Electrical Acupoint Stimulation on Quality of Recovery in Older Adults Undergoing Spinal Surgery

Effect of Transcutaneous Electrical Acupoint Stimulation on Quality of Recovery in Older Adults Undergoing Spinal Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001906
Enrollment
Unknown
Registered
2025-10-15
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative spinal disease

Interventions

TEAS group:Electrodes placed bilaterally at Neiguan (PC6), Hegu (LI4), Baihui (DU20), and Dazhui (DU14). Dense–disperse wave at 2/100 Hz
intensity set to the highest tolerable level without pain. Start 30 min before induction for 30 min
another 30-min session before entering PACU
then at 4 h, 8 h, and 12 h postoperatively, and on POD2 and POD3 at 07:00, 11:00, and 15:00, 30 min each. Device: HANS-200A acupoint nerve stimulator.
Control group:Same sites and schedule, but single frequency at 0.01 Hz with the lowest perceivable intensity. Both groups receive standard general anesthesia and perioperative analgesia (postoperative
parecoxib 40 mg IV bid for 2 days, then celecoxib 200 mg bid from POD3).

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: nclusion criteria Patients aged =65 years. Elective spine surgery involving =2 segments under general anesthesia. Willing to receive TEAS and provide written informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria Scarring or skin infection at the target acupoint sites for TEAS. Unable to understand pain scoring or to use the patient-controlled analgesia device. Uncontrolled severe heart disease, central nervous system disease, psychiatric disorder, or coagulopathy. Presence of a cardiac pacemaker.

Design outcomes

Primary

MeasureTime frame
QoR-15 total score at 24 hours postoperatively;

Secondary

MeasureTime frame
AUC of pain intensity at rest and on movement over 0–72 h postoperatively;Intraoperative opioid consumption;Cumulative postoperative opioid consumption within 0–72 h;Cumulative rescue analgesic consumption within 0–72 h;Incidence of postoperative delirium (POD1–POD3);Extubation time, PACU length of stay, time to first flatus, first oral intake, first ambulation, and postoperative length of stay;

Countries

China

Contacts

Public ContactMin Li

Peking university third hospital

liminanesth@bjmu.edu.cn13522757239

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026